Learn More
Medchemexpress LLC 4-(benzo[d]thiazol-2-ylthio)-3-chloroaniline | 300809-71-6 | MFCD00227023 | 99.9% | C13H9ClN2S2 | 10MG

Supplier: Medchemexpress LLC HY13749710MG
KRAS inhibitor-9 is a small-molecule research compound that blocks formation of GTP-bound KRAS and downstream KRAS signaling, inducing G2/M cell cycle arrest and apoptosis in responsive cells. It selectively reduces proliferation of KRAS-mutant non-small cell lung cancer cells and is supplied as a high-purity solid or as a DMSO solution for biochemical and cellular assays.
- Potent KRAS inhibition with measurable binding affinity.
- Selectively inhibits proliferation of KRAS-mutant non-small cell lung cancer cells.
- Induces G2/M cell cycle arrest and apoptosis in responsive cell lines.
- High purity and suitable for in vitro biochemical and cell-based assays.
- Available in multiple pack sizes and solution form for experimental convenience.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.